Curcumin can be used as an EGFR-TKI sensitizer to treat NSCLC with wild-type EGFR and a Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation. This evidence concerns the gene EGFR and non-small cell lung carcinoma.